Real-imaging cDNA-AFLP transcript profiling of pancreatic cancer patients: Egr-1 as a potential key regulator of muscle cachexia

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Skorokhod, Alexander ^a,d   Bachmann, Jeannine ^b   Giese, Nathalia A ^c   Martignoni, Marc E ^b   Krakowski Roosen, Holger ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; COMPLEMENTARY DNA; FIBRINOGEN ALPHA; TRYPSIN INHIBITOR; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ACUTE PHASE RESPONSE; AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; CACHEXIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EARLY RESPONSE GENE; EGR 1 GENE; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC CODE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; HYPOXEMIA; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE CONTRACTION; ONCOGENE; PANCREAS CANCER; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGED; BIOPSY; CACHEXIA; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PANCREATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 84862488757     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-265     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249. 10.3322/caac.20006, 19474385.
2. Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Buchler MW, Friess H, Martignoni ME. Cachexia worsens prognosis in patients with resectable pancreatic cancer. J GastrointestSurg 2008, 12:1193-1201.
3. Sacheck JM, Hyatt JP, Raffaello A, et al. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J 2007, 21:140-155.
4. Argiles JM, Busquets S, Felipe A, Lopez-Soriano FJ. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia. Int J Biochem Cell Biol 2005, 37:1084-1104. 10.1016/j.biocel.2004.10.003, 15743680.
5. Deans C, Wigmore SJ. Systemic inflammation, cachexia and prognosis in patients with cancer. CurrOpinClinNutrMetab Care 2005, 8:265-269.
6. Fortunati N, Manti R, Birocco N, et al. Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients. Oncol Rep 2007, 18:1521-1527.
7. Bachmann J, Ketterer K, Marsch C, et al. Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function. BMC Cancer 2009, 9:255. 10.1186/1471-2407-9-255, 2741486, 19635171.
8. Wittekind C. 2010 TNM system: on the 7th edition of TNM classification of malignant tumors. Pathologe 2010, 31:331-332.
9. Dellagi A, Birch PR, Heilbronn J, Lyon GD, Toth IK. cDNA-AFLP analysis of differential gene expression in the prokaryotic plant pathogen Erwiniacarotovora. Microbiology 2000, 146(Pt 1):165-171.
10. Ferrando AA, Wolfe RR. Restoration of hormonal action and muscle protein. Crit Care Med 2007, 35:S630-S634. 10.1097/01.CCM.0000278529.44899.57, 17713420.
11. Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117:399-412. 10.1016/S0092-8674(04)00400-3, 15109499.
12. Inui A, Meguid MM. Cachexia and obesity: two sides of one coin?. CurrOpinClinNutrMetab Care 2003, 6:395-399.
13. Baracos VE. Hypercatabolism and hypermetabolism in wasting states. CurrOpinClinNutrMetab Care 2002, 5:237-239.
14. Stephens NA, Gallagher IJ, Rooyackers O, et al. Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia. Genome Med 2010, 2:1. 10.1186/gm122, 2829926, 20193046.
15. Stevenson EJ, Koncarevic A, Giresi PG, Jackman RW, Kandarian SC. Transcriptional profile of a myotube starvation model of atrophy. J ApplPhysiol 2005, 98:1396-1406.
16. Jespersen J, Kjaer M, Schjerling P. The possible role of myostatin in skeletal muscle atrophy and cachexia. Scand J Med Sci Sports 2006, 16:74-82. 10.1111/j.1600-0838.2005.00498.x, 16533345.
17. Martignoni ME, Kunze P, Hildebrandt W, et al. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia. Clin Cancer Res 2005, 11:5802-5808. 10.1158/1078-0432.CCR-05-0185, 16115919.
18. Gustafsson MV, Zheng X, Pereira T, et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 2005, 9:617-628. 10.1016/j.devcel.2005.09.010, 16256737.
19. Carey KA, Farnfield MM, Tarquinio SD, Cameron-Smith D. Impaired expression of Notch signaling genes in aged human skeletal muscle. J Gerontol A BiolSci Med Sci 2007, 62:9-17.
20. Moses AG, Maingay J, Sangster K, Fearon KC, Ross JA. Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: Relationship to acute phase response and survival. Oncol Rep 2009, 21:1091-1095.
21. Fearon KC, Voss AC, Hustead DS. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 2006, 83:1345-1350.
22. Carballo-Jane E, Pandit S, Santoro JC, et al. Skeletal muscle: a dual system to measure glucocorticoid-dependent transactivation and transrepression of gene regulation. J Steroid BiochemMolBiol 2004, 88:191-201.
23. Dinarello CA, Kim SH. IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 2006, 65(Suppl 3):iii61-iii64. 1798381, 17038476.
24. Schmidt J, Stoffels B, Moore BA, et al. Proinflammatory role of leukocyte-derived Egr-1 in the development of murine postoperative ileus. Gastroenterology 2008, 135:926-936. 936, 10.1053/j.gastro.2008.05.079, 3319384, 18652830.
25. Yan SF, Fujita T, Lu J, et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 2000, 6:1355-1361. 10.1038/82168, 11100120.
26. McNamara MJ, Alexander HR, Norton JA. Cytokines and their role in the pathophysiology of cancer cachexia. JPEN J Parenter Enteral Nutr 1992, 16:50S-55S. 10.1177/014860719201600603, 1287224.